MEDIFAST INC
MEDNYSETrading Snapshot
- Day Range
- $12.13 – $12.62
- 52-Week Range
- $9.22 – $13.45
- Volume (shares)
- 192,743
- Avg Volume (shares)
- —
- Shares Outstanding
- 11.2M
- Next Earnings
- 2027-02-16
Fundamentals Snapshot
- Annual Revenue
- $386M
- Last Q Revenue
- $76M
- P/E Ratio
- —
- P/S Ratio
- 0.5x
- EPS (TTM)
- $-2.33
- Dividend Yield
- 0.12%
- Dilution (1yr)
- +0.1%
MEDIFAST INC
MED
StockOtter · stockotter.spaceAbout MEDIFAST INC
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
Medifast Is Running The Same Playbook, And I Have The Same Concerns
Medifast (MED) maintains a strong, cash-heavy balance sheet and trades near liquidation value, but its business model remains uninspiring amid GLP-1 disruption. Q3 2026 revenue declined 19.4% YoY to $72M, with active ear
Medifast Q3 Loss Narrower Than Expected as Coach Productivity Rises
MED tops Q3 earnings expectations as coach productivity jumps 54.1% and margins expand, despite declining revenues and a shrinking coach network.
Medifast, Inc. (MED) Q3 2026 Earnings Call Transcript
Medifast, Inc. (MED) Q3 2026 Earnings Call Transcript
What Medifast (MED) Said on Its Q3 Earnings Call
Medifast NYSE: MED reported third-quarter 2026 revenue of $72 million, down 19.4% from a year earlier, as the company continued to face a sharp decline in its active earning coach base. Management said revenue was within
Medifast (MED) Reports Q3 Loss, Tops Revenue Estimates
Medifast (MED) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.21 per share a year ago.
Medifast Announces Third Quarter 2026 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, today reported results for the third quarter ended